Novavax Inc (NVAX)

11.09
-0.14(-1.25%)
After Hours
11.10
+0.01(+0.09%)
- Real-time Data
  • Volume:
    4,037,439
  • Day's Range:
    10.95 - 11.44
  • 52 wk Range:
    8.75 - 101.39

NVAX Overview

Prev. Close
11.23
Day's Range
10.95-11.44
Revenue
1.62B
Open
11.11
52 wk Range
8.75-101.39
EPS
-17.14
Volume
4,037,439
Market Cap
953.51M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
6,911,872
P/E Ratio
-0.65
Beta
1.75
1-Year Change
-87.43%
Shares Outstanding
85,978,952
Next Earnings Date
Feb 27, 2023
What is your sentiment on Novavax?
or
Market is currently closed. Voting is open during market hours.

Novavax Inc News

Novavax Inc Analysis

Novavax Inc Company Profile

Novavax Inc Company Profile

Novavax, Inc., along with its wholly owned subsidiaries, Novavax AB and Novavax CZ, is a biotechnology company. The Company promotes improved health globally through the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Its recombinant technology platform harnesses the power and speed of genetic engineering to produce immunogenic nanoparticles designed to address urgent global health needs. The vaccine candidates in its near-term pipeline, including both coronavirus vaccine candidate (NVX-CoV2373) and seasonal quadrivalent influenza vaccine candidate (NanoFlu), which are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 is marketed under the brand name of Covovax or as Nuvaxovid COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]).

Read More

Analyst Price Target

Average55.33 (+398.95% Upside)
High110.00
Low13.00
Price11.09
No. of Analysts6
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellStrong Sell
Technical IndicatorsSellStrong SellStrong SellStrong SellStrong Sell
SummarySellStrong SellStrong SellStrong SellStrong Sell
  • Fenomenale recupero!
    1
    • I would not buy, nvax will need to raise more cash as they instead of selling need to repay governments for advance payments they received. only chance is a buyout for nvax and that I would only speculate below 10.
      4
      • Beneficial changes are in the works for NVAX. The stock will creep back to $18 levels with no news. If news it will move to the $30s quickly.
        1
        • Small prediction. NVAX will be trading above $14 in the near future.
          2
          • The viral game made a huge shift thus week. The power is back for NVAX as global demand rises.
            0
            • This stock is worth pennies. Keep shorting it.
              3
              • In mrkt to buy at 7.67$ , next week we are there
                1
                • Inept management and the results we have.
                  0
                  • this is getting close to (merger) arbitrage price. could make short term profit, risky though and currently better opportunities. in a bull market I would maybe buy below 10, speculating a takeover.
                    0
                    • Chapter 11 is unavoidable
                      1